ECE2017 Eposter Presentations: Diabetes, Obesity and Metabolism Obesity (81 abstracts)
Discussion with cases: Could we achieve the goal with non-surgical treatments in morbid obese patients?
Aydin Cifci 1 , Senay Arikan Durmaz 2 , Askin Gungunes 2 , Irfan Karahan 3 , Selim Yalcin 4 & Kubra Ozdemir 1
1Department of Internal Medicine, School of Medicine, Kirikkale University, Kirikkale, Turkey; 2Department of Endocrinology and Metabolism, School of Medicine, Kirikkale University, Kirikkale, Turkey; 3Department of Internal Medicine, Yenimahalle Traning and Research Hospital, Ankara, Turkey; 4Department of Oncology, School of Medicine, Kirikkale University, Kirikkale, Turkey.
Objective: Diet, lifestyle changes, medical agents and surgical approaches are treatment options in obese patients. We reported two morbid obese patients who lost 25 and 21% of their previous weight respectively with only lifestyle changes and orlistat therapy.
Case 1: Forty nine year-old woman had type 2 diabetes mellitus for 20 years. She took premix insulin twice a day. Her height was 157 cm, her weight was 120 kg, body mass index was 48.6 kg/m2. One month later, she lost 3 kg with diet and exercise and then orlistat was started. After seventh month of orlistat therapy, her weight reduced to 85 kg and body mass index was 34.4 kg/m2.
Case 2: Fifty-four year-old man has type 2 diabetes mellitus and took metformin for 10 years. His height was 168 cm, his weight was 118 kg, BMI was 41.8 kg/m2. One month later, he lost 2.5 kg with diet and exercise and then orlistat was started. After seventh month of orlistat therapy, his weight reduced to 93 kg and body mass index was 32.9 kg/m2. Both patients lost their weight 35 and 25 kg respectively with lifestyle changes and orlistat therapy. First year of treatment, patients maintain their weight without any gain.
Conclusion: The number of patients undergoing obesity surgery has increased at the present time. Patients prefer surgery instead of lifestyle changes. Our results of patients with morbid obese emphasize importance of lifestyle changes and orlistat therapy.
Article tools
My recent searches
My recently viewed abstracts
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more